Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Non-cash Items (2016 - 2020)

GT Biopharma (GTBP) has disclosed Non-cash Items for 9 consecutive years, with $40.0 as the latest value for Q3 2020.

  • On a quarterly basis, Non-cash Items changed N/A to $40.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $40.0, a N/A change, with the full-year FY2019 number at $40.0, changed N/A from a year prior.
  • Non-cash Items was $40.0 for Q3 2020 at GT Biopharma, roughly flat from $40.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1246.0 in Q4 2016 to a low of $40.0 in Q4 2019.
  • A 5-year average of $752.3 and a median of $1189.5 in 2016 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: crashed 99.54% in 2016, then changed 0.0% in 2017.
  • GT Biopharma's Non-cash Items stood at $1246.0 in 2016, then changed by 0.0% to $1246.0 in 2017, then changed by 0.0% to $1246.0 in 2018, then plummeted by 96.79% to $40.0 in 2019, then changed by 0.0% to $40.0 in 2020.
  • Per Business Quant, the three most recent readings for GTBP's Non-cash Items are $40.0 (Q3 2020), $40.0 (Q2 2020), and $40.0 (Q1 2020).